Clinical Microbiology Market Outlook, Trends And Future Opportunities (2024-2031)

Clinical Microbiology Market Outlook, Trends And Future Opportunities (2024-2031)

Clinical Microbiology Market, By Product (Instruments, Reagents), By Disease Area (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, Other Diseases), By End-user (Hospitals and Diagnostic Centers, Custom Lab Service Providers, Academic and Research Institutes), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Sep 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA171
  • Region: Global
  • Format: PDF/EXCEL

Table of Contents

Chapter 1. Research Methodology and Scope

  • Market Segmentation and Scope
  • Regional Coverage
  • Objectives
  • Research Methodology

Chapter 2. Executive Summary

  • Market Landscape
  • Market Size & Forecast
  • Competitive Landscape

Chapter 3. Clinical Microbiology Market: By Product Type Market Trends, Size, and Future Outlook

  • Product Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • Product Type Definitions, Technology Landscape
  • Product Type Market Drivers
    • Product Launches
    • Technology Launches
    • Other Relevant Market Drivers
  • Product Type Market Restraints

Chapter 4. Clinical Microbiology Market: By Application Market Trends, Size, and Future Outlook

  • Application Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • Application Definitions, Technology Landscape
  • Application Market Drivers
    • Product Launches
    • Technology Launches
    • Other Relevant Market Drivers
  • Application Market Restraints

Chapter 5. Clinical Microbiology Market: By Technology Market Trends, Size, and Future Outlook

  • Technology Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • Technology Definitions, Technology Landscape
  • Technology Market Drivers
    • Product Launches
    • Technology Launches
    • Other Relevant Market Drivers
  • Technology Market Restraints

Chapter 6. Clinical Microbiology Market: By End User Market Trends, Size, and Future Outlook

  • End User Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • End User Definitions, Technology Landscape
  • End User Market Drivers
    • Product Launches
    • Technology Launches
    • Other Relevant Market Drivers
  • End User Market Restraints

Chapter 7. Clinical Microbiology Market: By Test Type Market Trends, Size, and Future Outlook

  • Test Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • Test Type Definitions, Technology Landscape
  • Test Type Market Drivers
    • Product Launches
    • Technology Launches
    • Other Relevant Market Drivers
  • Test Type Market Restraints

Chapter 8. Clinical Microbiology Market: By Disease Area Market Trends, Size, and Future Outlook

  • Disease Area Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • Disease Area Definitions, Technology Landscape
  • Disease Area Market Drivers
    • Product Launches
    • Technology Launches
    • Other Relevant Market Drivers
  • Disease Area Market Restraints

Chapter 9. Clinical Microbiology Market: By Specimen Type Market Trends, Size, and Future Outlook

  • Specimen Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • Specimen Type Definitions, Technology Landscape
  • Specimen Type Market Drivers
    • Product Launches
    • Technology Launches
    • Other Relevant Market Drivers
  • Specimen Type Market Restraints

Chapter 10. Clinical Microbiology Market: Regional Market Trends, Size, and Future Outlook

  • North America Trends, Market Size (US$), CAGR (%), and Future Outlook
    • North America Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • North America Definitions, Technology Landscape
    • North America Market Drivers
      • Product Launches
      • Technology Launches
      • Other Relevant Market Drivers
    • North America Market Restraints
    • Competitive Outlook
  • Europe Trends, Market Size (US$), CAGR (%), and Future Outlook
    • Europe Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • Europe Definitions, Technology Landscape
    • Europe Market Drivers
      • Product Launches
      • Technology Launches
      • Other Relevant Market Drivers
    • Europe Market Restraints
    • Competitive Outlook
  • Asia Pacific Trends, Market Size (US$), CAGR (%), and Future Outlook
    • Asia Pacific Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • Asia Pacific Definitions, Technology Landscape
    • Asia Pacific Market Drivers
      • Product Launches
      • Technology Launches
      • Other Relevant Market Drivers
    • Asia Pacific Market Restraints
    • Competitive Outlook
  • Latin America Trends, Market Size (US$), CAGR (%), and Future Outlook
    • Latin America Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • Latin America Definitions, Technology Landscape
    • Latin America Market Drivers
      • Product Launches
      • Technology Launches
      • Other Relevant Market Drivers
    • Latin America Market Restraints
    • Competitive Outlook
  • Middle East & Africa Trends, Market Size (US$), CAGR (%), and Future Outlook
    • Middle East & Africa Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • Middle East & Africa Definitions, Technology Landscape
    • Middle East & Africa Market Drivers
      • Product Launches
      • Technology Launches
      • Other Relevant Market Drivers
    • Middle East & Africa Market Restraints
    • Competitive Outlook

Chapter 11. Clinical Microbiology Market: Competitive Landscape

  • BioMérieux SA
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Danaher Corporation (Cepheid)
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Becton, Dickinson and Company
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Roche Diagnostics
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Abbott Laboratories
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Bruker Corporation
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Siemens Healthineers
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • QIAGEN N.V.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Sysmex Corporation
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Hologic, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Accelerate Diagnostics, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Luminex Corporation (acquired by DiaSorin)
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • OpGen, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies

Research Methodology

  • Primary Research
  • Secondary Research
  • Assumptions
  • IDataAcumen Analysis
  • Paid Databases

Appendix

  • About Us

Frequently Asked Questions

The Clinical Microbiology Market was valued at approximately US$ 13.25 billion in 2024.

Increasing infectious disease prevalence, rising antimicrobial resistance, growing healthcare expenditure, technological advancements in diagnostics, shift towards molecular diagnostics, integration of AI in microbiology, expansion of point-of-care testing, automation in clinical laboratories, emerging markets growth, personalized medicine trends, NGS applications in diagnostics, collaborations with research institutions, aging population, and focus on preventive healthcare.

High costs, lack of skilled professionals, stringent regulations, limited reimbursement policies, and challenges in emerging markets.

The leading component segment is reagents, used for various diagnostic tests and analyses in clinical microbiology laboratories.

Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc.

The Clinical Microbiology Market is projected to grow at a CAGR of 5.8% to reach US$ 19.7 billion by 2031.

Increasing infectious diseases, technological advancements, growing awareness, rising healthcare expenditure, and demand for rapid diagnostic techniques.